Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (181-190 of 531) with videos related to

Pageof 54
Sort By:
The Journal of Antimicrobial Chemotherapy|April 1, 1988
Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureusP H Chandrasekar, D P Levine, S Price, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremiaThomas P Lodise, Peggy S McKinnon, Linda Swiderski, et al.
The American Journal of Gastroenterology|November 1, 1972
Lower gastrointestinal bleeding due to ulcerations in a Meckel's diverticulum and adjacent ileum with enteroliths formationM Haimov, B J Rybak, E I Greenberg, et al.
Pharmacotherapy|January 1, 1994
Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureusD Stanley, B J McGrath, K C Lamp, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2006
Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureusBrian T Tsuji, Michael J Rybak, Kerry L Lau, et al.
Pharmacotherapy|December 29, 2006
Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureusKerry L LaPlante, Michael J Rybak, Muhammad Amjad, et al.
Infectious Diseases and Therapy|August 20, 2014
Observation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strainsKatie E Barber, Cortney E Ireland, Natalia Bukavyn, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2015
Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolidKatie E Barber, Jordan R Smith, Animesh Raut, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of <i>Staphylococcus aureus</i> in a Simulated Pharmacodynamic/Pharmacokinetic ModelRazieh Kebriaei, Seth A Rice, Kyle C Stamper, et al.
Pharmacotherapy|May 18, 2023
Steno-sphere: Navigating the enigmatic world of emerging multidrug-resistant Stenotrophomonas maltophiliaAshlan J Kunz Coyne, Shelbye Herbin, Kaylee Caniff, et al.
Pageof 54

Showing results (181-190 of 531) with videos related to

Sort By:
Pageof 54
The Journal of Antimicrobial Chemotherapy|April 1, 1988
Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureusP H Chandrasekar, D P Levine, S Price, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremiaThomas P Lodise, Peggy S McKinnon, Linda Swiderski, et al.
The American Journal of Gastroenterology|November 1, 1972
Lower gastrointestinal bleeding due to ulcerations in a Meckel's diverticulum and adjacent ileum with enteroliths formationM Haimov, B J Rybak, E I Greenberg, et al.
Pharmacotherapy|January 1, 1994
Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureusD Stanley, B J McGrath, K C Lamp, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2006
Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureusBrian T Tsuji, Michael J Rybak, Kerry L Lau, et al.
Pharmacotherapy|December 29, 2006
Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureusKerry L LaPlante, Michael J Rybak, Muhammad Amjad, et al.
Infectious Diseases and Therapy|August 20, 2014
Observation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strainsKatie E Barber, Cortney E Ireland, Natalia Bukavyn, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2015
Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolidKatie E Barber, Jordan R Smith, Animesh Raut, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of <i>Staphylococcus aureus</i> in a Simulated Pharmacodynamic/Pharmacokinetic ModelRazieh Kebriaei, Seth A Rice, Kyle C Stamper, et al.
Pharmacotherapy|May 18, 2023
Steno-sphere: Navigating the enigmatic world of emerging multidrug-resistant Stenotrophomonas maltophiliaAshlan J Kunz Coyne, Shelbye Herbin, Kaylee Caniff, et al.
Pageof 54